Han Deok Kwak

Prof. Han Deok Kwak


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
HRHyo Seon Ryu
Hyo Seon Ryu
HKHyun Jung Kim
Hyun Jung Kim
WJWoong Bae Ji
Woong Bae Ji
BKByung Chang Kim
Byung Chang Kim
JKJi Hun Kim
Ji Hun Kim
KCKorean Colon Cancer Multidisciplinary Committee
Korean Colon Cancer Multidisciplinary Committee
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.

10 May 2019 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
HKHan Deok Kwak
Han Deok Kwak
JJJae Kyun Ju
Jae Kyun Ju
SLSoo Young Lee
Soo Young Lee
CKChang Hyun Kim
Chang Hyun Kim
YKYoung Jin Kim
Young Jin Kim
KHKim Chang Hyun
Kim Chang Hyun
Purpose: The colon originates from the midgut and hindgut, with subsequent differentiation into the right and left colon. The embryology, clinical symptoms, incidence, molecular pathways, and oncologic outcomes differ between right and left colorectal cancers. However, the differences have not been fully accepted. Aim of the Study: This study compared short- and long-term outcomes between right and left colon cancers. Materials and Methods: This study included 966 patients who underwent laparoscopic resection with radical lymph node dissection for stage I, II, and III colon cancers between 2009 and 2014 at a tertiary teaching hospital. We excluded cases with fewer than 12 retrieved lymph nodes, emergency operations, synchronous or multiple cancers, and those located in the transverse colon and rectum. Results: The right colon group included 343 (35.5%) patients and the left colon group 623. Female patients had a high incidence of right colon cancer (p < 0.001). Right colon cancer had longer operative times (p = 0.012), and more bleeding during the operation (p = 0.001). The size of the tumor was larger (p < 0.001) and more lymph nodes were harvested (p < 0.001) on the right side. Vascular (p = 0.006) and lymphatic (p = 0.004) invasion was greater in the right colon, but left colon cancer showed greater neural invasion (p = 0.008). Cancers on the right side also had a tendency to be poorly differentiated (p < 0.001). The groups did not differ in disease-free, overall, and cancer-specific survival rates for stage. Conclusion: Although the oncologic outcomes show no significant differences, colon cancer has characteristic, perioperative, and histopathologic differences according to its embryologic origin.

31 December 2019 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
HKHan Deok Kwak
Han Deok Kwak
JJJae Kyun Ju
Jae Kyun Ju
There are known differences in embryology, clinical symptoms, incidences, molecular pathways involved, and oncologic outcomes of right-sided and left-sided colorectal cancers. However, immunologic study has only been characterized for healthy adults. The present study was designed to identify differences in immune cell populations in patients with right-sided and left-sided colorectal cancers. A total of 35 patients who underwent colorectal resection for cancer between November 2016 and August 2017 at a tertiary teaching hospital were enrolled in this study. Patients were excluded if they had a disease affecting their immune system. Populations of immune cells, including mucosal-associated invariant T (MAIT), gamma delta T, invariant natural killer T, T, natural killer, and B cells, were measured in the peripheral blood and cancer tissues using flow cytometry, and then assessed based on the origin of the colorectal cancer. Fifteen had right-side and 20 had left-side colorectal cancer. There were no significant differences between the 2 cohorts for patient characteristics including pathologic stage. Peripheral blood from patients with right-side colon cancers contained fewer MAIT (0.87% right-side vs. 1.74% left-side, P = 0.028) and gamma delta T cells (1.10% right-side vs. 3.05% left-side, P = 0.002). Although the group with right-side colorectal cancer had more MAIT cells in cancer tissues (1.71% vs. 1.00%), this difference was not statistically significant. There is a difference in population sizes of immune cells in blood between patients with right-sided and leftsided colon cancers. The immune cell composition was determined to be distinct based on embryologic origin.

1 January 2023 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
JCJun Seong Chung
Jun Seong Chung
JJJae Kyun Ju
Jae Kyun Ju
HKHan Deok Kwak
Han Deok Kwak
Chung JS, et al. Ann Surg Treat Res. 2023 Mar;104(3):150-155. https://doi.org/10.4174/astr.2023.104.3.150

24 March 2023 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
HKHan Deok Kwak
Han Deok Kwak
JCJun Seong Chung
Jun Seong Chung
HKHan Deok Kwak
Han Deok Kwak

28 February 2026 in Annals of Coloproctology
Verified
Journal Article
Open access
HRHyo Seon Ryu
Hyo Seon Ryu
HKHyun Jung Kim
Hyun Jung Kim
DKDong Hyun Kang
Dong Hyun Kang
YKYoo-Kang Kwak
Yoo-Kang Kwak
HKHan Deok Kwak
Han Deok Kwak
JKJung-Myun Kwak
Jung-Myun Kwak
Rectal cancer, which accounts for approximately 40% of colorectal cancers, remains a major clinical concern. Recent advances in diagnostic imaging, surgical techniques, radiotherapy, and systemic treatment have steadily improved rectal cancer outcomes. Considering this, the Korean Rectal Cancer Multidisciplinary (KRCM) Committee has aimed to provide clinicians and policymakers with up-to-date, evidence-based clinical practice guidelines to support optimal decision-making, reflecting current evidence, the Korean healthcare context, and patient values and preferences. The Clinical Practice Guidelines for Rectal Cancer version 2.0 were developed through multidisciplinary collaboration with related academic societies, building upon and updating the KRCM Clinical Practice Guidelines version 1.0 (titled “Multidisciplinary guidelines for the management of rectal cancer”). These consensus guidelines of the KRCM were established based on a comprehensive literature review, evidence synthesis, with recommendation development guided by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, and consideration of applicability in real-world clinical practice under the national health insurance system. Each recommendation has been presented with its strength and level of evidence.